Preparation method of garlic essential oil inclusion compound liposome and its application in lowering blood lipid

By improving the preparation method of garlic essential oil inclusion complex liposomes, utilizing sterols and phospholipids to form a lipid membrane, and combining it with ultrasonic treatment, the stability and sustained release problems of garlic essential oil inclusion complex were solved, achieving constant-rate release in gastrointestinal fluid and significant lipid-lowering effect.

CN117860839BActive Publication Date: 2024-11-19OCEAN UNIV OF CHINA
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202311730388.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-15
Publication Date
2024-11-19
Estimated Expiration
2043-12-15

AI Technical Summary

Technical Problem

Existing garlic essential oil inclusion complex liposomes have shortcomings in terms of stability and lipid-lowering effect. Direct consumption can irritate the gastrointestinal tract, and existing inclusion methods are prone to particle aggregation and poor sustained-release effect.

Method used

An improved preparation method was used to dissolve garlic essential oil microcapsules with sterols or saponins and phospholipids in a solvent to form a lipid membrane. After hydration and ultrasonic treatment, a garlic essential oil inclusion complex liposome aqueous dispersion was prepared, which improved its stability and sustained-release effect.

Benefits of technology

The prepared garlic essential oil inclusion complex liposomes exhibited constant-rate release with zero-order kinetics in gastrointestinal fluid, demonstrating high stability and significant lipid-lowering effects, making them suitable for the preparation of lipid-lowering drugs and health foods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117860839B_ABST
    Figure CN117860839B_ABST
Patent Text Reader

Abstract

The present invention provides a preparation method of garlic essential oil inclusion liposome and its application in reducing blood lipids. After the garlic essential oil microcapsules obtained by wall material embedding treatment are dispersed in water, they are added to a lipid film for hydration to obtain a garlic essential oil inclusion liposome aqueous dispersion; the hydration time is 5 to 15 minutes; the garlic essential oil microcapsules are dispersed in water, and the mass volume concentration in the aqueous dispersion is 0.85 to 1.25 g / L; the lipid film is prepared by dissolving sterols or saponins and phospholipids in a solvent to obtain a lipid solution, and then removing the solvent to form a film; the mass ratio of the garlic essential oil microcapsules to the phospholipids is 1:4 to 10. The garlic essential oil inclusion liposome has good stability in storage, heat, pH value and gastrointestinal fluid environment, and the drug release is slow and constant, which can significantly reduce the body's blood lipids, improve drug utilization, and improve liver damage caused by hyperlipidemia; it can be used to prepare drugs for reducing blood lipids or hyperlipidemia metabolic diseases, and auxiliary blood lipid-lowering health foods and beverages.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of pharmaceutical preparations, and in particular to a method for preparing garlic essential oil inclusion compound liposomes and application thereof in reducing blood lipids. Background Art

[0002] Blood lipids are a general term for neutral fats and lipids in plasma, including triglycerides, phospholipids, glycolipids, sterols and steroids, etc. They are essential substances for the basic metabolism of cells and participate in the body's energy metabolism and the synthesis of cell plasma membranes and steroid hormones. When the blood lipid content is too high and cannot be metabolized in time, it will cause a variety of diseases; for example, hypercholesterolemia is a lipid metabolism disease in the blood. The drugs used clinically for treatment mainly include statins, resins, cholesterol absorption inhibitors, niacin, etc., but these drugs all have serious adverse reactions, such as muscle pain, liver and kidney damage, elevated blood sugar-induced diabetes, severe gastrointestinal reactions, etc. Therefore, it is of great significance to develop a drug or health product with no adverse reactions and lipid-lowering effects to control and improve blood lipid content to prevent and treat diseases caused by hyperlipidemia.

[0003] Garlic Essential Oil (GEO) is a volatile essential oil with a pungent odor extracted from garlic. It has a bright, transparent amber appearance and contains a variety of allyl sulfides, including a large amount of allicin, diallyl trisulfide compounds, methyl allyl sulfide compounds and ajoene, etc. It can be used in many fields such as medicine, food, and animal feed. GEO has many physiological activities, mainly including improving immunity, antibacterial and anti-inflammatory, preventing cardiovascular diseases, anti-cancer and anti-tumor, preventing liver diseases, and lowering blood lipids. However, GEO is unstable to light and heat, is volatile, and direct consumption will cause irritation to the gastrointestinal mucosa, which greatly limits its application in food, medicine, and health products. In order to improve the application value of GEO, the existing technology improves its physical and chemical stability by embedding GEO into wall materials. For example, the Chinese invention patent with publication number CN102961713A discloses a ginger-garlic enteric-coated tablet and a preparation method thereof, which uses ginger and garlic essential oil as raw materials and is prepared by inclusion of β-cyclodextrin to form ginger-garlic enteric-coated tablets; however, directly using cyclodextrin to include garlic essential oil has poor thermal stability and is prone to degradation; the prior art also uses liposomes to include garlic essential oil, but the inclusion particles of liposome-included garlic essential oil are prone to aggregation, which is not conducive to storage stability; at the same time, the garlic essential oil included by the above two methods has poor stability in the gastrointestinal tract and poor sustained-release effect, which also leads to poor effect for reducing blood lipids. Therefore, it is necessary to develop a method for preparing garlic essential oil inclusion liposomes that can improve the stability of garlic essential oil and its blood lipid-lowering effect. Summary of the invention

[0004] The purpose of the present invention is to solve the above technical problems and provide a garlic essential oil inclusion compound liposome with better stability and better blood lipid lowering effect, which is achieved by improving the preparation method of the garlic essential oil inclusion compound liposome; another purpose of the present invention is to provide an application of the garlic essential oil inclusion compound liposome; and a further purpose of the present invention is to provide a composite pomegranate juice beverage using the garlic essential oil inclusion compound liposome.

[0005] To achieve the above object, the present invention adopts the following technical solutions:

[0006] The method for preparing garlic essential oil inclusion compound liposomes is to disperse garlic essential oil microcapsules obtained by wall material embedding treatment in water, add the microcapsules into lipid membranes for hydration, and obtain garlic essential oil inclusion compound liposome water dispersion;

[0007] The hydration time is 5 to 15 minutes; the garlic essential oil microcapsules are dispersed in water, and the mass volume concentration of the garlic essential oil microcapsules in the water dispersion is 0.85 to 1.25 g / L;

[0008] The lipid membrane is obtained by dissolving sterols or saponin and phospholipids in a solvent to obtain a lipid solution, and then removing the solvent to form a membrane to obtain the lipid membrane; the mass ratio of the garlic essential oil microcapsules to the phospholipids is 1:4-10, and further, the mass ratio of the garlic essential oil microcapsules to the phospholipids is preferably 1:6.

[0009] The present invention scientifically applies the technical idea of ​​twice embedding, is cleverly applied to the preparation of garlic essential oil inclusion compound liposome, and is specifically combined with the characteristics of garlic essential oil inclusion compound, and summarizes that encapsulation rate and stability are the key to successful drug preparation. If the encapsulation rate is not good, the drug carrying and sustained release will be affected, the stability is poor, and it is not conducive to the storage of garlic essential oil inclusion compound liposome, and the drug release in the body. Based on this, the present invention obtains a lipid solution by dissolving sterols or saponin and phospholipid in a solvent, and then forms a lipid film after removing the solvent, and then hydrates with garlic essential oil microcapsules, and determines the key conditions such as the mass volume concentration of the hydration time and the garlic essential oil microcapsules in the aqueous dispersion, summarizes the influence of key processes and conditions on stability, determines a reasonable embedding sequence and process conditions, and prepares a garlic essential oil inclusion compound liposome aqueous dispersion. The garlic essential oil inclusion compound liposome aqueous dispersion has high stability and good sustained release effect, has storage, heat, pH value and simulated gastrointestinal fluid stability, and its release in gastrointestinal fluid conforms to the zero-order kinetic equation, and the release mechanism is constant rate release, and the drug release stability is high. At the same time, the garlic essential oil inclusion liposome aqueous dispersion has a therapeutic effect on hyperlipidemia, a hyperlipidemia metabolic disease, and can significantly reduce blood lipid content, improve the utilization of garlic essential oil in the body, and improve the antioxidant capacity of liver tissue caused by hyperlipidemia, as well as liver damage and inflammation.

[0010] Furthermore, the solvent is anhydrous ethanol, methanol, n-hexane or chloroform. The solvent can dissolve sterols, saponins, and phospholipids, and has a different melting point from these substances and is easily volatilized and separated. More preferably, the present invention uses anhydrous ethanol as the solvent.

[0011] Furthermore, the mass ratio of the sterol substance or saponin to the phospholipid is 1:2 to 4. As a common embodiment, the sterol substance can be sterol or cholesterol. As a common embodiment, the phospholipid can be lecithin, soybean lecithin, egg yolk lecithin or soybean lecithin.

[0012] Furthermore, the sterol substance is preferably cholesterol; and the phospholipid is preferably lecithin.

[0013] More preferably, when the sterol substance is cholesterol and the phospholipid is lecithin, the mass ratio of cholesterol to lecithin is 1:3.

[0014] Furthermore, the lipid membrane is obtained by dissolving sterols, phospholipids and antioxidants in a solvent to obtain a lipid solution, and then removing the solvent.

[0015] Preferably, the antioxidant is one or any combination of vitamin E, vitamin C, n-acetylcysteine, glutathione or β-carotene. Adding antioxidants can prevent phospholipids from being oxidized and increase their stability. Preferably, the mass ratio of the antioxidant to phospholipids is 1:10-1:40. Too much antioxidant will affect the phospholipid coating.

[0016] Furthermore, the wall material is preferably cyclodextrin, and the cyclodextrin is β-cyclodextrin, α-cyclodextrin or γ-cyclodextrin.

[0017] In addition, the garlic essential oil inclusion liposome aqueous dispersion can be post-processed to make the particle size of the garlic essential oil inclusion liposome therein more uniform and smaller.

[0018] Furthermore, the method for preparing the garlic essential oil inclusion compound liposome comprises the following steps:

[0019] S1. dissolving sterols or saponins and phospholipids in a solvent at a mass ratio of 1:2 to 4 to obtain a lipid solution;

[0020] S2. The lipid solution is placed in a container and a lipid film is formed, and an aqueous dispersion of garlic essential oil microcapsules encapsulated by a wall material is added to the lipid film and hydrated to obtain an aqueous liposome dispersion;

[0021] S3. The liposome aqueous dispersion obtained in S2. is subjected to ultrasonic treatment and microporous organic filter membrane treatment.

[0022] Furthermore, the ultrasonic treatment in step S3 is to control the particle size distribution of the liposomes in the liposome aqueous dispersion to be between 50 nm and 800 nm.

[0023] As an practicable manner, the ultrasonic treatment in step S3 is performed by using an ultrasonic cell disruptor in an ice bath at a power of 120 W for 5 to 11 minutes.

[0024] Preferably, the liposome aqueous dispersion in step S3 is obtained by dispersing garlic essential oil microcapsules in PBS aqueous buffer.

[0025] Furthermore, the garlic essential oil microcapsules encapsulated by the wall material in step S2 are obtained by adding garlic essential oil to a saturated aqueous solution of the wall material so that the mass ratio of the garlic essential oil to the wall material is 1:4-8, stirring and freezing, freeze-thawing and precipitation, melting and drying to remove moisture.

[0026] Furthermore, the saturated aqueous solution of the wall material in step S2 is a saturated aqueous solution with a dissolution temperature of 15 to 35°C.

[0027] Furthermore, after the ultrasonic treatment in step S3, the product needs to be extruded through a 0.45 μm microporous organic filter membrane.

[0028] Preferably, the container in step S2 is a rotary evaporator, and the evaporation conditions are: vacuum, temperature 35° C., rotation speed 150 rpm, and rotary evaporation until the solvent is completely removed.

[0029] Preferably, the freeze-thaw precipitation time is 3 to 5 hours.

[0030] The present invention has found through experiments that the garlic essential oil inclusion compound liposome prepared according to the above method not only has better stability and sustained release effect, but also has better blood lipid lowering effect, and can have a therapeutic effect on hypercholesterolemia.

[0031] The present invention claims protection for the use of the garlic essential oil inclusion compound liposome prepared by the garlic essential oil inclusion compound liposome preparation method in the preparation of drugs for lowering blood lipids or hyperlipidemia metabolism diseases, and auxiliary blood lipid-lowering health foods or functional beverages.

[0032] Preferably, the hyperlipidemia metabolic disease is hypercholesterolemia.

[0033] The invention provides a composite pomegranate juice beverage, which comprises 10% to 15% by volume of concentrated pomegranate juice and 1.5% to 2.5% of a garlic essential oil inclusion compound liposome aqueous dispersion prepared by the above preparation method.

[0034] Furthermore, in order to obtain a good combination of health-care activity and taste, the compound pomegranate juice beverage also includes sweeteners and other flavoring agents.

[0035] Furthermore, the composite pomegranate juice beverage includes 10% to 15% by volume of concentrated pomegranate juice and 1.5% to 2.5% of the garlic essential oil inclusion liposome aqueous dispersion, as well as 40 to 80 g / L of white sugar and 0.2 to 0.6 g / L of citric acid in a mass volume concentration.

[0036] Furthermore, the composite pomegranate juice beverage also includes a stabilizer. A preferred embodiment is that the combination and dosage of the stabilizer are: the mass volume concentrations in the composite pomegranate juice beverage are 1.2 g / L pectin, 1.4 g / L sodium alginate and 0.3 g / L gellan gum, respectively.

[0037] The beneficial effects of the present invention are as follows:

[0038] (1) The garlic essential oil inclusion compound liposome prepared by the present invention has high stability and good sustained-release effect, and has storage, heat, pH value and simulated gastrointestinal fluid stability. Its release in gastrointestinal fluid conforms to the zero-order kinetic equation, the release mechanism is constant-rate release, and the drug release stability is high.

[0039] (2) The garlic essential oil inclusion liposome has a therapeutic effect on hyperlipidemia, a disease related to hyperlipidemia metabolism, and can significantly reduce blood lipid content, improve the utilization of garlic essential oil in the body, and improve the antioxidant capacity of liver tissue caused by hyperlipidemia, as well as liver damage and inflammation.

[0040] (3) The garlic essential oil inclusion compound liposome is simple to prepare and has a wide range of applications. It can be used to prepare drugs for lowering blood lipids or hyperlipidemia metabolism diseases, and auxiliary blood lipid-lowering health foods or functional beverages.

[0041] (4) The composite pomegranate juice beverage of the present invention is successfully prepared by compounding and modulating the garlic essential oil inclusion compound liposome with concentrated pomegranate juice, which has good sensory evaluation, stable system, and has both pomegranate juice and garlic essential oil inclusion compound liposome composite functional beverage, which can be used to assist in lowering blood lipids. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1 The influence of various factors on the encapsulation rate in the preparation of garlic essential oil inclusion liposomes;

[0043] Figure 1 A is the ratio of cholesterol to lecithin, B is the mass ratio of garlic essential oil β-cyclodextrin microcapsules to lecithin, C is the lipid membrane hydration time, D is the ultrasonic time of the liposome solution, and E is the mass volume concentration of garlic essential oil microcapsules in the aqueous dispersion; the same letters or those containing the same letters in the figures indicate no significant difference.

[0044] Figure 2The electron microscope particle size images of GEO-DCLs and garlic essential oil liposome GEO-CLs, and the DSC spectra of GEO-DCLs, blank liposomes, and GEO-β-CD;

[0045] Figure 2 A is the appearance of GEO-CLs, B is the transmission electron microscopy image of GEO-CLs, C is the particle size distribution diagram of GEO-CLs, D is the appearance of GEO-DCLs, E is the transmission electron microscopy image of GEO-DCLs, F is the particle size diagram of GEO-DCLs, and G is the DSC spectrum of GEO-β-CD, blank liposomes and GEO-DCLs.

[0046] Figure 3 The effect of different mass volume concentrations of garlic essential oil microcapsules in aqueous dispersion on the average particle size and storage stability;

[0047] Figure 3 A represents the change of average particle size over time; B represents the change of Zeta potential over time.

[0048] Figure 4 It is the stability test of garlic essential oil inclusion liposome GEO-DCLs, garlic essential oil β-cyclodextrin microcapsules GEO-β-CD and garlic essential oil liposome GEO-CLs;

[0049] Figure 4 A and B show the pH stability and thermal stability of Free-GEO, GEO-β-CD, GEO-CLs and GEO-DCLs, respectively; C, D, E, and F show the changes in encapsulation efficiency, particle size, PDI, and Zeta potential of GEO-CLs and GEO-DCLs samples when stored at 4°C and 25°C for 28 days, respectively.

[0050] Figure 5 The stability and release rate of garlic essential oil inclusion liposomes GEO-DCLs, garlic essential oil β-cyclodextrin microcapsules GEO-β-CD and garlic essential oil liposomes GEO-CLs in the gastrointestinal tract;

[0051] Figure 5 A and B are the stabilities of Free-GEO, GEO-β-CD, GEO-CLs and GEO-DCLs in gastric and intestinal fluids after 6 h of incubation, respectively; C is the cumulative release rate of garlic essential oil in GEO-CLs and GEO-DCLs in simulated gastric fluid; and D is the cumulative release rate of garlic essential oil in GEO-CLs and GEO-DCLs in simulated intestinal fluid.

[0052] Figure 6The fitting curves of the zero-order kinetic equation, the first-order kinetic equation and the Higuchi equation of garlic essential oil inclusion liposome GEO-DCLs and garlic essential oil liposome GEO-CLs in simulated gastrointestinal fluid;

[0053] Figure 6 A, B, and C represent GEO-CLs simulating gastric juice, D, E, and F represent GEO-DCLs simulating gastric juice, G, H, and I represent GEO-CLs simulating intestinal juice, and J, K, and L represent GEO-DCLs simulating intestinal juice.

[0054] Figure 7 The effect of garlic essential oil inclusion liposomes GEO-DCLs on the body weight and body fat of hyperlipidemic mice;

[0055] Figure 7 A represents the changes in the body weight of mice in each group over time; B represents the Lee's index of mice in each group; C represents the fat index of mice in each group; D represents the liver coefficient of mice in each group; E represents the deposition size of epididymal fat and perirenal fat; Figure 7 The significance level indicates the comparison with the normal group, ***P<0.001, **P<0.01, *P<0.05; the significance level indicates the comparison with the model group, ###P<0.001, ##P<0.01, #P<0.05.

[0056] Figure 8 The effect of garlic essential oil inclusion liposome GEO-DCLs on blood lipid levels and liver function indexes in hyperlipidemic mice;

[0057] Figure 8 A is the serum TC content of mice in each group, B is the serum TG content of mice in each group, C is the serum HDL-C content of mice in each group, and D is the serum LDL-C content of mice in each group; E is the AST content of each group, F is the ALT content of each group, G is the GSH-Px content of each group, H is the MDA content of each group, I is the SOD content of each group, J is the representative liver tissue H&E staining image of different groups (200×), and K is the representative adipose tissue H&E staining image of different groups (100×).

[0058] Fig. 9 It is a sensory evaluation of a single factor experiment on a compound pomegranate juice beverage;

[0059] Fig. 9 A is the sensory score of the amount of pomegranate juice added, B is the amount of GEO-DCLs added, C is the amount of white sugar added, and D is the amount of citric acid added. The same letters or those containing the same letters in the figures indicate no significant difference.

[0060] Fig.10It is the microscopic images of GEO-DCLs composite pomegranate juice beverage and Free-GEO composite pomegranate juice beverage and the stability test of GEO-DCLs composite pomegranate juice beverage;

[0061] Fig.10 A and B are microscopic images (100×) of GEO-DCLs composite pomegranate juice beverage and Free-GEO composite pomegranate juice beverage, respectively; C is the change in centrifugal sedimentation rate of the composite pomegranate juice beverage during storage; D is the color change during storage; E is the change in soluble solid content during storage; and F is the change in pH value during storage. DETAILED DESCRIPTION

[0062] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0063] Example 1

[0064] The method for preparing garlic essential oil inclusion compound liposome comprises the following steps:

[0065] S1. dissolving cholesterol and lecithin in a mass ratio of 1:3 in anhydrous ethanol as a solvent to obtain a lipid alcohol solution, and adding an antioxidant to prevent lecithin from oxidation;

[0066] Cholesterol belongs to the sterols, and in actual preparation, saponin or other sterols can be used as conventional substitutes; lecithin belongs to a type of phospholipids, and in actual preparation, soy lecithin, egg yolk lecithin or soy lecithin can be used as conventional substitutes; for solvents, other solvents such as methanol, n-hexane or chloroform can also be used as conventional substitutes, and ethanol is the preferred reagent of this scheme because it is non-toxic. Antioxidants can be selected from vitamin E, and can also be conventionally replaced with other conventional antioxidants, such as vitamin C, n-acetylcysteine, glutathione or β-carotene.

[0067] S2. Place the lipid alcohol solution in a rotary evaporator and perform rotary evaporation until the ethanol is completely removed, wherein the evaporation conditions are 35°C and 150 rpm under vacuum; a lipid film is formed on the inner wall of the rotary evaporator, and a β-cyclodextrin-encapsulated garlic essential oil microcapsule aqueous dispersion is added to the lipid film, and hydration is performed for 10 minutes to obtain a liposome aqueous dispersion, wherein the β-cyclodextrin-encapsulated garlic essential oil microcapsule is prepared by adding garlic essential oil to a cyclodextrin saturated aqueous solution at 25°C, so that the mass ratio of garlic essential oil to β-cyclodextrin is 1:6, and the mixture is stirred and frozen, and freeze-thawed and precipitated, and the freeze-thaw precipitation time is 4 hours; the mixture is melted and dried to remove water; the mass ratio of the cyclodextrin-encapsulated garlic essential oil microcapsule to the lecithin forming the lipid film is 1:6.

[0068] As an optional solution, cyclodextrin is the wall material for encapsulating garlic essential oil. In actual preparation, other conventional wall materials such as α-cyclodextrin or γ-cyclodextrin can also be used as substitutes. As an optional solution, the cyclodextrin saturated aqueous solution can be a saturated aqueous solution with a dissolution temperature of 15 to 35°C.

[0069] S3. The liposome aqueous dispersion is sonicated for 8 minutes at a power amplification intensity of 120 W in an ice bath using an ultrasonic cell crusher to reduce the liposome particle size. After the sonication is completed, it is also required to be extruded through a 0.45 μm microporous organic filter membrane to remove liposomes with excessively large particle sizes to obtain a homogeneous garlic essential oil inclusion complex liposome aqueous dispersion.

[0070] The specific preparation experiment operation is as follows:

[0071] First, a certain mass ratio of cholesterol and lecithin (1:3, 0.086 g and 0.25 g, respectively) was dissolved in 24 mL of anhydrous ethanol, and 0.0125 g of vitamin E was added as an antioxidant.

[0072] Then, the absolute ethanol was completely evaporated under vacuum at 35°C and 150 rpm using a rotary evaporator until a lipid film was formed on the wall, and the formed lipid film was hydrated with a buffered aqueous solution of cyclodextrin-encapsulated garlic essential oil microcapsules (garlic essential oil β-cyclodextrin microcapsules) at ambient temperature for 10 min, containing a garlic essential oil inclusion complex liposome aqueous dispersion;

[0073] The garlic essential oil microcapsule buffered aqueous solution is obtained by dissolving 0.042 g of garlic essential oil microcapsules in 40 mL of buffered aqueous solution PBS, the mass ratio of cyclodextrin-encapsulated garlic essential oil microcapsules to the lecithin forming the lipid membrane is 1:6, and the mass volume concentration of the garlic essential oil microcapsules in the aqueous dispersion is 1.05 g / L.

[0074] The specific process of preparation of garlic essential oil β-cyclodextrin microcapsules GEO-β-CD is as follows: 0.80 g of β-cyclodextrin is dissolved in 50 mL of distilled water at a dissolution temperature of 25 °C to prepare a supersaturated solution, and then garlic essential oil is added according to the core-wall ratio (the mass ratio of garlic essential oil and β-cyclodextrin is 1:6, 0.13 g and 0.80 g respectively), and after magnetic stirring for 20 min, it is placed in a -18 °C refrigerator, and after freeze-thaw precipitation for 4 h, it is taken out of the refrigerator, filtered after it melts, and then dried in a 50 °C drying oven to constant weight to obtain β-cyclodextrin microcapsules.

[0075] Finally, the garlic essential oil inclusion liposome aqueous dispersion was ultrasonicated for 8 minutes at an amplification intensity of 120 W in an ice bath by an ultrasonic cell crusher, and extruded through a 0.45 μm microporous organic filter membrane to obtain a homogeneous garlic essential oil β-cyclodextrin inclusion liposome aqueous dispersion.

[0076] Example 2-3

[0077] The preparation method is the same as that in Example 1, except that only the volume of the buffered aqueous solution PBS is changed so that the mass volume concentration of the garlic essential oil microcapsules in the aqueous dispersion is 0.85 g / L and 1.25 g / L respectively, and the other steps remain unchanged to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0078] Comparative Example 1-2

[0079] The preparation method is the same as that in Example 1, except that only the volume of the buffered aqueous solution PBS is changed so that the mass volume concentration of the garlic essential oil microcapsules in the aqueous dispersion is 0.65 g / L and 1.45 g / L respectively, and the other steps remain unchanged to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0080] Embodiment 4-5

[0081] The preparation method is the same as that in Example 1, except that only the hydration time is changed to 5 min and 15 min, and the other steps remain unchanged, to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0082] Comparative Example 3

[0083] The preparation method is the same as that in Example 1, except that only the hydration time is changed to 20 min, and the other steps remain unchanged, to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0084] Embodiment 6-8

[0085] The preparation method is the same as that in Example 1, except that only the amount of cholesterol added is changed so that the mass ratios of cholesterol to lecithin are 1:2, 1:4 and 1:5 respectively, and the other steps remain unchanged to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0086] Examples 9-11

[0087] The preparation method is the same as that in Example 1, except that only the content of garlic essential oil microcapsules included in cyclodextrin is changed, and the content of lecithin is kept unchanged, so that the mass ratio of lecithin to lecithin is 1:4, 1:8 and 1:10 respectively, and the other steps are unchanged to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0088] Comparative Examples 4-5

[0089] The preparation method is the same as that in Example 1, except that only the content of garlic essential oil microcapsules included in cyclodextrin is changed, and the content of lecithin is kept unchanged, so that the mass ratios of lecithin to lecithin are 1:2 and 1:12 respectively, and other steps remain unchanged to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0090] Examples 12-14

[0091] The preparation method is the same as that in Example 1, except that only the ultrasonic time is changed to 2 min, 5 min and 11 min, and the other steps remain unchanged to prepare a liposome aqueous dispersion containing garlic essential oil β-cyclodextrin inclusion complex.

[0092] Embodiment 15

[0093] A composite pomegranate juice beverage comprises 12.5% ​​by volume of concentrated pomegranate juice, 2.0% of a liposome aqueous dispersion containing garlic essential oil inclusion complex prepared in Example 1, 60 g / L of white sugar and 0.4 g / L of citric acid by mass volume concentration, and a stabilizer, wherein the mass volume concentrations of the stabilizer in the composite pomegranate juice beverage are 1.2 g / L of pectin, 1.4 g / L of sodium alginate, and 0.3 g / L of gellan gum.

[0094] Examples 16-18

[0095] A composite pomegranate juice beverage, compared with the composite pomegranate juice beverage of Example 15, only the volume percentage of concentrated pomegranate juice is changed to 7.5%, 10% and 15% respectively, and other formulas are the same as those of Example 15.

[0096] Comparative Example 6

[0097] A composite pomegranate juice beverage, compared with the composite pomegranate juice beverage of Example 15, only the volume percentage of concentrated pomegranate juice is changed to 5%, and other formulas are the same as those of Example 15.

[0098] Examples 19-20

[0099] A composite pomegranate juice beverage, compared with the composite pomegranate juice beverage of Example 15, only the volume percentage of the garlic essential oil inclusion liposome aqueous dispersion is changed to 1.5% and 2.5% respectively, and the other formulas are the same as those of Example 15.

[0100] Comparative Examples 7-8

[0101] A composite pomegranate juice beverage, compared with the composite pomegranate juice beverage of Example 15, only the volume percentage of the garlic essential oil inclusion liposome aqueous dispersion is changed to 3.0% and 3.5% respectively, and the other formulas are the same as those of Example 15.

[0102] Examples 21-24

[0103] A composite pomegranate juice beverage, compared with the composite pomegranate juice beverage of Example 15, only the mass volume concentration of white sugar is changed to 20g / L, 40g / L, 80g / L and 100g / L, and the other formulas are the same as those of Example 15.

[0104] Examples 25-28

[0105] A composite pomegranate juice beverage, compared with the composite pomegranate juice beverage of Example 15, only the mass volume concentration of citric acid is changed to 0.2g / L, 0.6g / L, 0.8g / L and 1.0g / L, and the other formulas are the same as those of Example 15.

[0106] Experimental Example 1 Encapsulation Efficiency Determination

[0107] 1. Experimental Methods

[0108] Take 2 mL of the garlic essential oil inclusion liposome aqueous dispersion prepared in Examples 1-14 and Comparative Examples 1-5, add anhydrous ethanol to break the membrane and dilute to 40 mL, measure the absorbance at a wavelength that does not interfere with the garlic essential oil, and record it as A1; take another 2 mL of the same sample, ultracentrifuge at low temperature for 40 min (10000 r / min), suck out the supernatant, extract with petroleum ether 3 times, collect and combine the extracts, evaporate the petroleum ether, add anhydrous ethanol to dilute to 40 mL, and measure the absorbance at a wavelength that does not interfere with the garlic essential oil, and record it as A2. Substitute A1 and A2 into the standard curve equation, calculate the concentrations C1 and C2 to obtain the mass W1 and W2 of the garlic essential oil.

[0109] According to the formula: The liposome encapsulation efficiency was calculated.

[0110] 2. Experimental results

[0111] The single factor experimental results were obtained by investigating the mass volume concentration of garlic essential oil microcapsules in water dispersion, the ratio of cholesterol to lecithin, the mass ratio of garlic essential oil β-cyclodextrin microcapsules to lecithin, the lipid membrane hydration time and the ultrasonic time of liposome solution. Figure 1 .

[0112] Cholesterol can increase the fluidity of lipid membranes and improve the encapsulation efficiency and appearance of liposomes, but excessive cholesterol use can lead to liposome instability. Figure 1 As shown in A, when the amount of lecithin is fixed, as the amount of cholesterol increases, the encapsulation rate increases first and then decreases (Example 1 and Examples 6-8). When the addition ratio of cholesterol to lecithin is 1:3 (Example 1), the encapsulation rate reaches a maximum value of 82.9%. Liposomes are mainly composed of drugs and phospholipids. The water-soluble cyclodextrin drug inclusion complex will be dispersed in the inner water phase of phospholipids and is relatively stable. Under the premise of ensuring the liposome encapsulation rate, the amount of phospholipids should be reduced as much as possible. Figure 1 As shown in B, when the drug-lipid ratio is 1:6 (Example 1), the encapsulation rate reaches the maximum value, and the drug-lipid ratio from 1:4 to 1:10 has a good encapsulation rate (Examples 9-11), but when the drug-lipid ratio is too large to 1:2 or too small to 1:12 (Comparative Examples 4-5), the encapsulation rate is low. The lipid film formed after rotary evaporation needs to be hydrated with a suitable hydrating medium for a certain period of time to form liposomes. PBS is selected as the hydrating medium, which can increase the pH stability of the liposome system; Figure 1 As shown in Figure C, the encapsulation efficiency reaches a maximum value of 84.48% when the lipid film hydration time is 10 minutes (Example 1). When the hydration time is controlled at 5 minutes to 15 minutes (Examples 4-5), it has a higher encapsulation efficiency. When the hydration time is increased and the hydration time is 20 minutes (Comparative Example 3), the encapsulation efficiency decreases. The particle size of the liposome obtained by thin film hydration is relatively large and is not easy to store for a long time. After a certain period of ultrasound, the particle size of the liposome is reduced, thereby increasing its storage time. Figure 1 As shown in D, with the increase of ultrasonic time, the encapsulation rate first increases and then decreases (Examples 12-14). By ultrasonic treatment for a certain time, the particle size of the liposome is reduced to a certain extent, thereby improving the encapsulation rate. However, if the ultrasonic time is too long, the emulsion will break, resulting in the release of a large amount of garlic essential oil, and then the encapsulation rate will decrease. Figure 1As shown in E, the mass volume concentration of garlic essential oil microcapsule in aqueous dispersion is too low or too high (Comparative Examples 1-2), which will lead to the decline of encapsulation efficiency, and only when the mass volume concentration is 0.85g / L~1.25g / L, the encapsulation efficiency is higher (Example 1-3), and when the mass volume concentration is 1.25g / L, the encapsulation efficiency maximum is reached. When the mass volume concentration (water and concentration) of garlic essential oil microcapsule in aqueous dispersion is relatively small, the encapsulation efficiency is not high, and the reason is that the lecithin concentration is too low, and all garlic essential oil microcapsules can not be wrapped, along with the increase of hydration concentration, the encapsulation efficiency presents a trend of increasing first and then decreasing, and the encapsulation efficiency is the maximum when the hydration concentration is 1.05g / L, and then the hydration concentration is too large, which means that the hydration volume is too small, and at this time, the lipid film can not be fully hydrated, and then the liposome formed can not fully wrap all garlic essential oil microcapsules, so the encapsulation efficiency declines.

[0113] Experimental Example 2 Characterization of Inclusion Condition

[0114] 1. Experimental Methods

[0115] For Example 1 and the garlic essential oil liposome aqueous dispersion GEO-CLs prepared by liposome-encapsulated garlic essential oil according to the method of Example 1, and the garlic essential oil microcapsules GEO-β-CD included in β-cyclodextrin prepared according to the method of Example 1 were used as comparisons for appearance morphology, transmission electron microscopy and particle size analysis, and their Zeta potential polydispersity index (Polymer Dispersity Index, PDI) and differential scanning calorimetry (Differential Scanning Calorimetry, DSC) were analyzed respectively to characterize the inclusion of Example 1 and the comparative samples.

[0116] 2. Experimental results

[0117] (1) Appearance, electron microscopy and particle size analysis

[0118] like Figure 2 A. By observation, the garlic essential oil liposome GEO-CLs aqueous dispersion was milky white, without aggregated particles or precipitation. Figure 2 B. Through electron microscopy, the morphology of garlic essential oil liposomes GEO-CLs is round or oval, and the particle size is mostly around 180nm. Figure 2 C, the particle size of garlic essential oil liposome GEO-CLs showed a normal unimodal distribution, with an average particle size of (190.8±2.52) nm (n=3, n represents independent repeated experiments) and a polydispersity coefficient of 0.201±0.063, indicating that the particle size distribution of garlic essential oil liposome GEO-CLs was relatively uniform.

[0119] like Figure 2The appearance of the DGEO-DCLs aqueous dispersion (the homogeneous garlic essential oil β-cyclodextrin inclusion liposome aqueous dispersion prepared in Example 1) was milky white, and no aggregated particles or precipitation were observed. Figure 2 E, The electron microscopy image shows that the liposomes are round or oval in shape, and most of the particle sizes are around 240 nm. It also shows that some liposome particles are aggregated, which may be related to the temperature of the preparation environment. As the temperature rises, the liposomes adhere to each other and form aggregates. Figure 2 F, the particle size diagram shows a unimodal distribution, the average particle size is (236.3±2.37) nm (n=3), and the polydispersity index (PDI) is (0.22±0.022) (n=3), indicating that the particle size distribution of the GEO-DCLs solution is uniform.

[0120] (2) Zeta potential and dispersion index

[0121] Zeta potential is a measure of the strength of mutual repulsion or attraction between particles. It is one of the important indicators for characterizing the stability of colloidal dispersions. The larger its absolute value, the more charge it carries and the more stable the system. Conversely, the smaller the absolute value of Zeta potential, the easier it is for liposomes to aggregate, resulting in an unstable system. According to the Zeta potential instrument, garlic essential oil liposomes are negatively charged, with an average Zeta potential of -65.5mV, and the system is relatively stable (Table 1).

[0122] Table 1 Average Zeta potential of garlic essential oil liposome solution

[0123]

[0124] The Zeta potential of GEO-DCLs was (-66.67 ± 1.03) mV (n = 3), indicating that the surface of GEO-DCLs was negatively charged, and the absolute value of the charge was greater than 30 mV, indicating that there was a large electrostatic repulsion between particles, which was beneficial to the stability of the inclusion liposomes (Table 2).

[0125] Table 2 Average Zeta potential of GEO-DCLs

[0126]

[0127] (3) Differential Scanning Calorimetry

[0128] Depend on Figure 2G It can be seen that the curve of garlic essential oil microcapsules encapsulated by β-cyclodextrin has been in an exothermic state, and there is an obvious exothermic peak at 290.25℃, which indicates that the cyclodextrin structure has been destroyed, the garlic essential oil is exposed and oxidative decomposition has occurred. In addition, the curve trends of GEO-DCLs and blank liposomes are roughly the same, and the exothermic peak at 290.25℃ in the GEO-β-CD curve is not seen in the GEO-DCLs curve, which indicates that the cyclodextrin microcapsules are not destroyed at this temperature, but successfully enter the central water chamber of the liposomes, and the liposomes play a certain protective role on the microcapsules, which also proves the successful inclusion of the garlic essential oil microcapsules encapsulated by β-cyclodextrin, and the cyclodextrin liposomes have achieved the effect of double-layer encapsulation of garlic essential oil.

[0129] Experimental Example 3 Stability Determination

[0130] 1. Experimental Methods

[0131] (1) pH stability, storage stability and thermal stability

[0132] a. Effect of different mass volume concentrations of garlic essential oil microcapsules in aqueous dispersion on average particle size and storage stability

[0133] The average particle size change and Zeta potential change of the garlic essential oil β-cyclodextrin inclusion liposome aqueous dispersion prepared in Examples 1-3 and Comparative Examples 1-2 were tested in a short period of 0-8 days.

[0134] b. Stability test of free garlic essential oil, garlic essential oil liposomes GEO-CLs, β-cyclodextrin-encapsulated garlic essential oil microcapsules GEO-β-CD and garlic essential oil β-cyclodextrin inclusion liposome aqueous dispersions.

[0135] The pH stability, thermal stability and storage stability of free garlic essential oil, garlic essential oil liposome aqueous dispersion GEO-CLs prepared by encapsulating garlic essential oil with liposomes according to the method of Example 1, β-cyclodextrin-encapsulated garlic essential oil microcapsules GEO-β-CD prepared according to the method of Example 1, and garlic essential oil β-cyclodextrin inclusion liposomes in Example 1 were tested. The pH stability is the retention rate of garlic essential oil at pH 7.4; the storage stability is the change of encapsulation rate, particle size, PDI and Zeta potential after storage at 4°C and 25°C for 0-28 days, and its long-term stability is measured; the thermal stability is the retention rate of garlic essential oil after heat treatment for 30, 60, 90, and 120 minutes.

[0136] (2) Gastrointestinal fluid stability and release kinetics

[0137] The stabilities of free garlic essential oil (10 μg / mL), garlic essential oil microencapsulated GEO-β-CD, garlic essential oil liposomes, and garlic essential oil β-cyclodextrin inclusion liposomes (GEO-DCLs) were studied in simulated stomach (SGF, pH 1.2) and intestine (SIF, pH 6.8).

[0138] The specific method is: garlic essential oil liposomes and garlic essential oil β-cyclodextrin inclusion liposomes are placed in the prepared gastric juice, kept in a water bath at 37°C, stirred at a speed of 100r / min, and placed in a SHA-B digital constant temperature oscillator. Simulate the digestion function of human gastric juice, measure the release of garlic essential oil once every 1h, inactivate the enzyme at 92°C for 2min, incubate in SGF for 6h, and measure the absorbance value at 215nm by a visible spectrophotometer to calculate the release amount. The digestion process of simulated intestinal juice is the same as that of simulated gastric juice.

[0139] Calculate the cumulative release rate:

[0140]

[0141] Higuchi equation: Q = kt 1 / 2 (Ⅱ)

[0142] Zero-order kinetic equation: Q = kt (Ш)

[0143] First-order kinetic equation: Q = 1-e -kt (VI)

[0144] In formula (I): Q t is the cumulative release rate of garlic essential oil at time t, %; M t is the garlic essential oil content released at time t, mg; M o is the garlic essential oil content in the liposomes at the initial moment of release, mg.

[0145] In formula (II), (Ш) and (VI), Q is the cumulative release rate; k is the characteristic constant of the nutrient release system; and t is the digestion time.

[0146] 2. Experimental results

[0147] (1) Effects of different mass volume concentrations of garlic essential oil microcapsules in aqueous dispersion on average particle size and short-term storage stability

[0148] Zeta potential can characterize the stability of the dispersed system. The larger the absolute value of Zeta potential, the more stable the emulsion is. Figure 3 As shown by Figure 3It can be seen that the garlic essential oil β-cyclodextrin inclusion liposomes prepared in Examples 1-3 and Comparative Examples 1-2 will change in particle size in a short period of time when the mass volume concentration of garlic essential oil microcapsules in the aqueous dispersion is 0.65g / L and 1.45g / L. The reason may be that the particle fusion caused by the instability of the system leads to an increase in particle size. When the mass volume concentration is 0.85g / L-1.25g / L (Examples 1-3), the average particle size changes little in a short period of time. Figure 3 B It can be seen that the garlic essential oil β-cyclodextrin inclusion compound liposomes prepared in Examples 1-3 and Comparative Examples 1-2 will experience rapid changes in Zeta potential in a short period of time when the mass volume concentration of the garlic essential oil microcapsules in the aqueous dispersion is 0.65g / L and 1.45g / L, and the stability of the system is significantly reduced; while when the mass volume concentration is 0.85g / L-1.25g / L, the system is relatively stable and the change in Zeta potential is low. It can be seen that only when the mass volume concentration of the garlic essential oil microcapsules in the aqueous dispersion is 0.85g / L-1.25g / L, the system is stable in a short period of time (8 days).

[0149] (2) pH stability and thermal stability

[0150] The experimental results are as follows Figure 4 As shown in the figure, after 180 min of treatment at pH = 7.4, the free garlic essential oil was rapidly degraded and the retention rate dropped sharply, while the garlic essential oil encapsulated by liposomes or dextrin was only slightly degraded. Compared with GEO-β-CD and GEO-CLs, the retention rate of garlic essential oil in GEO-DCLs was the highest, which indicates that GEO-DCLs can better inhibit the degradation of garlic essential oil at pH = 7.4 and has better pH stability ( Figure 4 A).

[0151] Compared with Free-GEO and GEO-β-CD, the retention rate of garlic essential oil in the two garlic essential oil liposome preparations was the highest after heat treatment at 60℃ for 30min, reaching more than 90%, which indicates that liposome encapsulation has a better protective effect on garlic essential oil. After heat treatment for 120min, Free-GEO has been completely degraded, and the retention rate of garlic essential oil in GEO-CLs and its GEO-β-CD has dropped to 40%, while the retention rate of garlic essential oil in GEO-DCLs remains at about 70%, which indicates that GEO-DCLs have better thermal stability ( Figure 4 B), the deep embedding of garlic essential oil in the bilayer provides it with better protection, which is mainly attributed to the denser molecular packing of the bilayer and the more ordered multilamellar vesicle structure.

[0152] (3) Long-term storage stability

[0153] The experimental results are as follows Figure 4 As shown in the figure, aggregation, deposition, phospholipid oxidation and hydrolysis of liposomes during storage limit their application and performance as nanocarriers. Therefore, the storage stability of liposomes is an important indicator for evaluating carrier performance. After storage at 4°C for 28 days, the encapsulation efficiency and particle size of GEO-CLs and GEO-DCLs did not change much, and the PDI value and zeta potential were within the stable range, indicating that GEO-CLs and GEO-DCLs have good storage stability at 4°C.

[0154] When the liposome samples were stored at 25°C, the storage stability variation trend between different liposome samples was more prominent. After 28 days of storage, the encapsulation efficiency of GEO-CLs decreased significantly, and the particle size increased significantly ( Figure 4 C and D), PDI and zeta potential fluctuate within a stable range ( Figure 4 E and F). The encapsulation efficiency of GEO-DCLs only decreased slightly, the particle size increased from 217.4nm to 377.6nm, and the PDI and potential fluctuated within a stable range. Compared with GEO-CLs, GEO-DCLs are not easy to aggregate and fuse, and it can be clearly seen from the encapsulation efficiency and particle size that GEO-DCLs have more stable storage stability. Fusion and aggregation occurred between GEO-CLs particles, and the particles increased, which is mainly attributed to the fact that liposomes are thermodynamically unstable systems, and liposomes accelerate lipid oxidation and chain reactions under high temperature. This result is consistent with the research results that garlic essential oil liposomes are easy to aggregate at high temperatures. From the above experimental results, it can be seen that higher temperatures are not conducive to the storage stability of liposomes.

[0155] (4) Stability and release in simulated gastrointestinal fluid

[0156] Gastrointestinal fluid stability results Figure 5 As shown in the figure, GEO is easily digested and absorbed under extremely acidic conditions, so Free-GEO was significantly degraded after incubation in simulated gastric fluid for 6 h ( Figure 5 A). In addition, after incubation in simulated gastric fluid for 4 h, the retention rate of GEO in GEO-β-CD also dropped sharply. This may be because cyclodextrin was hydrolyzed into glucose and a series of non-cyclic maltose under high acid conditions, and the destruction of the cyclodextrin structure led to the release of GEO in large quantities. Compared with GEO-DCLs, GEO-CLs have poor stability, which may be due to the destruction of the liposome membrane caused by the hydrolysis of the ester bond connecting the fatty acid and the glycerol backbone at acidic pH, resulting in a large amount of GEO drug leakage. In summary, GEO-DCLs have better stability in simulated gastric fluid. After incubation in simulated intestinal fluid for 4 h ( Figure 5B) Free-GEO is decomposed in large quantities in intestinal fluid because GEO itself corrodes and irritates the intestinal mucosa, destroys the normal physiological structure of the intestinal biofilm, and thus increases vascular permeability. However, after GEO is made into an inclusion compound, direct contact between GEO and the intestinal mucosa can be avoided, and the drug will not be concentrated locally, thereby reducing its irritation to the intestinal mucosa and having a certain oral safety.

[0157] The release of GEO-CLs in simulated gastric fluid showed a trend of sustained release, while that of GEO-DCLs showed a trend of first slowly increasing and then gradually releasing ( Figure 5 C). The release of GEO from GEO-CLs reached more than 70% after 6 hours of digestion, which may be due to the destruction of the liposome membrane, the continuous release of GEO, and the poor sustained release effect. However, the release of GEO-DCLs reached a maximum of 33% after 6 hours of digestion. At the beginning of digestion, the low release of GEO in GEO-DCLs may be due to the protective effect of β-CD on GEO. As the digestion proceeded under strong acid conditions, the liposome structure was partially destroyed, cyclodextrin was hydrolyzed into glucose and non-cyclic maltose, and garlic essential oil was released from cyclodextrin one after another, so its release gradually increased. In summary, GEO-DCLs have a better sustained release effect on GEO.

[0158] The cumulative release rate of GEO-CLs in simulated intestinal fluid showed a trend of rapid increase at first and then uniform release, while GEO-DCLs showed a trend of uniform release ( Figure 5 D). The study found that after 2 hours of digestion, the cumulative release rate of GEO in GEO-DCLs was 26%, which was lower than that in GEO-CLs. This may be because the β-CD in GEO-DCLs increased the rigidity of the liposome membrane, reduced the micropolarity inside the membrane, and made the molecules more tightly bound, which effectively reduced the permeability of the membrane and the action sites of trypsin, thereby enhancing the tolerance to enzymes. With the extension of digestion time, the cumulative release rate of garlic essential oil in the garlic essential oil liposome preparation showed a slow growth trend. At 6 hours, the cumulative release rate reached 70%, achieving the sustained release behavior of GEO in the intestinal fluid.

[0159] (4) Analysis of the fitting equation results of the release amount in simulated gastrointestinal fluid

[0160] Zero-order kinetic equation, first-order kinetic equation and Higuchi equation are commonly used to evaluate the release behavior of liposomes. For sustained-release preparations, first-order kinetic equation and Higuchi equation are often used for fitting, and for controlled-release preparations, zero-order kinetic equation is often used for fitting. The release mechanism of sustained-release preparations is Fick diffusion, while the release mechanism of controlled-release preparations is constant-rate release. Both mechanisms can explain the slow release behavior of nutrients. Figure 6A, B, C and G, H, I show that the digestion behavior of GEO-CLs in simulated gastrointestinal fluid conforms to the Higuchi equation, and the release mechanism is Fick diffusion. Figure 6 D, E, F and J, K, L show that the digestion behavior of GEO-DCLs in simulated gastrointestinal fluid conforms to the zero-order kinetic equation, and the release mechanism is constant-rate release.

[0161] Experimental Example 4 Animal Experiment

[0162] 1. Experimental Methods

[0163] (1) Study on the lipid-lowering effect in animals

[0164] Male C57BL / 6N mice (8 weeks old) were obtained from Charles River Laboratory Animal Technology (Beijing, China). All mice were kept at 22-25°C, 55±15% humidity, 12 h light / dark cycle, with unlimited access to food and water. All mice were adapted to normal diet for one week, during which time they were provided with sufficient drinking water and stable temperature.

[0165] One week later, the rats were weighed and randomly divided into cages. One group continued to be fed with ordinary feed, which was the blank control group. The other seven groups were model group: high-fat diet group; empty liposome group: high-fat diet + blank liposome; GOM group: high-fat diet + high-dose GEO-DCLs (20 mg / Kg); GON group: high-fat diet + medium-dose GEO-DCLs (10 mg / Kg); GOO group: high-fat diet + low-dose GEO-DCLs (5 mg / Kg); GOL group: high-fat diet + blank liposome + free garlic essential oil (20 mg / Kg); positive drug: simvastatin group (1.5 mg / Kg). Kg); except for the blank control group, the 7 experimental groups were fed with high-fat feed during the experiment. The 4 groups of GOM, GOO, GON and GOL were given once a day by oral gavage. At the same time, the empty liposome group was given a certain amount of liposome treatment by oral gavage, and the model group and the blank control group were given a certain amount of distilled water treatment by oral gavage. The feeding time was 6 weeks, and their health conditions were observed every day, their body weights were weighed every week, and the final body weights were recorded. The high-dose GEO-DCLs, medium-dose GEO-DCLs and low-dose GEO-DCLs were all dosed according to the above requirements when the samples in Example 1 were administered.

[0166] At the end of the experiment, all mice were anesthetized with chloral hydrate after fasting for 12 h; then, blood was quickly collected from the eyeballs, centrifuged at 12000g and 4°C for 10 min to separate serum, and stored at -20°C for later use. When the mice were killed, the liver and epididymal fat were collected, photographed and weighed correctly, the fat index and liver coefficient were calculated, and histological and biochemical analyses were performed.

[0167] 2. Experimental results

[0168] (1) Establishment of hypercholesterolemia model

[0169] After 6 weeks of high-fat diet, the blood lipid parameters of mice are shown in Table 3. Compared with the normal control group, the serum TC level in the high-fat model group was significantly increased (P < 0.001), while the serum TG level was not increased, indicating that the hypercholesterolemia model was successfully established.

[0170] Table 3 Effects of high-fat diet on blood lipid parameters in mice fed for 6 weeks

[0171]

[0172] (2) Effects of GEO-DCLs on body weight and body fat of HFD-induced mice

[0173] After 6 weeks of high-fat diet and drug intervention, the average body weight of mice in the model group increased significantly compared with the control group (p<0.001) ( Figure 7 A), Lee's index increased significantly (0.001>p<0.01) ( Figure 7 B), fat index increased significantly (p<0.001) ( Figure 7 C), liver coefficient increased significantly (P<0.001) ( Figure 7 D), epididymal fat and perirenal fat deposition are obvious ( Figure 7 E).

[0174] During the experimental period, there was a significant difference in the average body weight curves between the model group and the GEO-DCLs high-dose intervention group (p<0.001), indicating that GEO-DCLs could alleviate the weight gain of mice induced by a high-fat diet ( Figure 7 A). Compared with the model group, the Lee's index in the GEO-DCLs high-dose intervention group was significantly reduced (0.001>p<0.01) ( Figure 7 B),

[0175] The fat index of each GEO-DCLs intervention group was significantly reduced ( Figure 7 C), the liver coefficient of mice in the high- and medium-dose groups of GEO-DCLs was significantly reduced (P<0.001), and the liver coefficient of mice in the blank liposome group was also reduced, which indicated that blank liposomes and garlic essential oil played a synergistic role in lowering blood lipids, and also indicated that GEO-DCLs could effectively intervene in the increase of liver weight in mice and reduce their liver coefficient ( Figure 7 D). Finally, the addition of GEO-DCLs significantly reduced the weight and size of adipose tissue in mice, indicating that GEO-DCLs can effectively reduce fat deposition in mice ( Figure 7 E).

[0176] (3) Effects of GEO-DCLs on blood lipid indexes in high-fat fed mice

[0177] By measuring the TG content in mouse serum, it was found that the triglyceride level of mice in the model group did not increase, and there was no significant difference between the groups, which shows that the model established is hypercholesterolemia ( Figure 8 B).

[0178] Compared with the normal group, the serum TC and LDL-C levels of the mice in the model group were significantly increased (P<0.001), and the HDL-C level was significantly decreased (P<0.001); compared with the model group, the serum TC and LDL-C levels of the mice in the GEO-DCLs high-dose intervention group (dose of 20 mg / Kg / d) were significantly decreased ( Figure 8 A. Figure 8 D), HDL-C level increased significantly ( Figure 8 C). Studies have shown that the contribution of GEO to lowering blood lipids and preventing obesity is 46.3 mg / kg / d. From the above results, it can be concluded that DCLs has a good protective effect on GEO and improves the bioavailability of GEO, so that GEO can achieve a slow release effect in mice.

[0179] (4) Effects of GEO-DCLs on liver damage, lipid peroxidation, and liver pathological changes in high-fat-fed mice

[0180] Effect of GEO-DCLs on liver injury in high-fat-fed mice Figure 8 As shown in the literature, ALT and AST are key indicators of liver function and can reflect the degree of liver damage. ALT and AST are ubiquitous in hepatocytes. When hepatocytes die, ALT and AST enter the blood, leading to an increase in serum enzymes. Increased levels of ALT and AST have been shown to be consistent with the level of hepatocyte damage. The AST and ALT levels of mice in the high-fat model group were significantly higher than those in the normal control group (P<0.001), indicating that a high-fat diet causes liver damage in mice ( Figure 8 E and F). Compared with the model group, the GEO-DCLs intervention group was able to significantly reduce the ALT and AST levels in the mouse serum (P<0.05). These results indicate that GEO-DCLs improved the degree of liver damage in mice.

[0181] Effects of GEO-DCLs on lipid peroxidation in high-fat fed mice Figure 8 As shown in Figure 2, the levels of GSH-Px and SOD in the high-fat model group were significantly lower than those in the normal control group (P<0.001), indicating that a high-fat diet reduced the antioxidant capacity of the liver tissue of mice ( Figure 8 G and Figure 8I). The levels of GSH-Px and SOD in the mice of the high-dose and medium-dose GEO-DCLs groups were significantly higher than those in the high-fat model group (P<0.001). Compared with the normal control group, the MDA level in the liver tissue of the high-fat model group was significantly increased (P<0.001), indicating that a high-fat diet leads to increased lipid peroxidation and decreased antioxidant capacity ( Figure 8 H). Compared with the model group, the MDA content in the liver tissue homogenate of mice in the high-dose and medium-dose GEO-DCLs groups was significantly reduced (P<0.001). These results indicate that GEO-DCLs intervened in the increase of MDA levels in mice fed a high-fat diet to a certain extent, thereby reducing the degree of lipid peroxidation in the body and protecting the integrity of cell structure and function.

[0182] Effects of GEO-DCLs on liver pathological changes in high-fat-fed mice Figure 8 As shown in the figure, compared with the normal control group, the model group mice had less hepatocyte tissue and more fat vacuoles, indicating that there were more lipid droplets stored in the hepatocytes and the cell nuclei were enlarged and irregular ( Figure 8 J), indicating that the high-fat diet caused certain damage and inflammation to the mouse liver. The study found that the number of round lipid droplets in the cytoplasm was reduced in all GEO-DCLs intervention groups, and the cell nucleus also tended to normalize. The fat cells of mice in the HFD group were significantly larger than those in the control group. Compared with the model group, the fat cells of mice in the high-dose and medium-dose GEO-DCLs groups were significantly reduced, and the fat cells in the blank liposome group were also reduced, but the effect was not significant ( Figure 8 K), which indicates that blank liposomes have a certain inhibitory effect on the enlargement of adipocytes in mice induced by a high-fat diet, indicating that liposomes and garlic essential oil play a synergistic role in alleviating liver damage and inflammation in mice fed a high-fat diet.

[0183] Experimental Example 5 Sensory Evaluation of Composite Pomegranate Juice Beverage

[0184] 1. Experimental Methods

[0185] The pomegranate juice beverages prepared in Examples 15-28 and Comparative Examples 6-9 were subjected to sensory evaluation to analyze the sensory characteristics of the pomegranate juice beverages. The sensory scoring criteria are shown in Table 4.

[0186] Table 4 Sensory scoring standards

[0187]

[0188]

[0189] 2. Experimental results

[0190] The experimental results are as follows Fig. 9 As shown, Fig. 9A, the sensory score of pomegranate juice added in an amount of 7.5% to 15% (Examples 5-18) first increases and then decreases, reaching the highest score at 12.5% ​​(Example 15). At this time, the pomegranate juice has a strong aroma. If the pomegranate juice is further added, the acidity will also increase, resulting in a worse taste. When the pomegranate juice is added in an amount less than 12.5%, the beverage will have insufficient aroma and a light taste. When the addition amount is 5% (Comparative Example 6), the garlic essential oil tastes too strong and the score is low. Garlic essential oil has a unique flavor. A small amount of garlic essential oil flavor will make people happy, but a strong garlic essential oil flavor will make people feel spicy and irritating. Fig. 9 B shows that when the addition amount of GEO-DCLs is 1.5% to 2.5% (Example 15 and Example 19-20), the sensory score of the beverage increases first and then decreases. When the addition amount of GEO-DCLs is low, the aroma of the garlic essential oil will be masked by the aroma of the pomegranate juice itself, while when the addition amount of GEO-DCLs is higher than 3% (Comparative Example 7 and Comparative Example 8), the aroma of the garlic essential oil will be highlighted, resulting in a heavier taste and a decrease in people's acceptance. The optimal addition amount of GEO-DCLs is 2%. Fig. 9 C shows that when the addition range of white sugar is 6% to 10% (mass volume concentration is 60 to 100 g / L, corresponding to Examples 15 and 23-24), the low addition amount (20 to 40 g / L, corresponding to Examples 21-22) affects the overall taste of the beverage, so adding 6% (mass volume concentration is 60 g / L) of white sugar is the best. Fig. 9 D It can be seen that when the amount of citric acid added increases, the sensory score trend of the beverage increases first and then decreases (Examples 15 and Examples 25-28). The beverage tastes best at 0.04% (mass volume concentration is 0.4g / L, corresponding to Example 15). When less citric acid is added, the beverage is sweet and does not meet the taste of most people. When the amount of citric acid added is greater than 0.04%, the finished product is sour, and the increase in acidity causes the garlic essential oil to have a prominent aroma, affecting the pomegranate juice flavor. Therefore, the optimal amount of citric acid added is determined to be 0.04%.

[0191] Experimental Example 6 Stability Analysis of Composite Pomegranate Juice Beverage

[0192] 1. Experimental Methods

[0193] (1) Microscopic analysis

[0194] The composite pomegranate juice beverage of Example 15 was mixed with a pomegranate juice beverage having the same components as Example 15 but with only the same amount of garlic essential oil (Free-GEO) added thereto, and the uniformity of the particles thereof under a microscope was measured.

[0195] (2) Stability test

[0196] The composite pomegranate juice beverage of Example 15 was stored for 0 to 15 days, and its centrifugal sedimentation rate was tested. The determination method was as follows: the composite pomegranate juice beverage was stored at 4° C. for 0, 3, 6, 9, 12, and 15 days, and the centrifugal sedimentation rate of the composite pomegranate juice beverage was determined. During centrifugation, m sample solution was taken and centrifuged in a centrifuge tube. The centrifugation conditions were: 4000 r / min, centrifugation for 15 min, and then the mass m1 of the solid matter after centrifugation was weighed, and the centrifugal sedimentation rate was calculated according to the following formula.

[0197] Centrifugal sedimentation rate (%) = (m1 / m) × 100%

[0198] Where m is the total mass of the sample solution; m1 is the mass of the precipitate after centrifugation.

[0199] The changes of L*, a*, and b* values ​​over time were measured using a colorimeter; and the changes of solid content and pH in the beverage were also measured.

[0200] 2. Experimental results

[0201] (1) Microscopic analysis results are shown in Fig.10 ,Depend on Fig.10 A shows that GEO-DCLs are evenly dispersed in the pomegranate juice beverage, and the emulsion particles are uniform in size and stable in nature. Fig.10 B shows that the particle size of Free-GEO in pomegranate juice beverage is uneven, the dispersion is uneven, and the properties are unstable; this may be due to the poor water solubility of Free-GEO and its strong garlic smell, so it cannot be directly used in pomegranate juice beverage.

[0202] (2) Stability test results are as follows Fig.10 As shown in Figure 2, the smaller the centrifugal sedimentation rate, the more stable the beverage. Fig.10 C shows that the centrifugal sedimentation rate of the composite pomegranate juice beverage gradually increases within 15 days of storage, which indicates that the precipitation in the pomegranate juice beverage gradually increases and the system gradually becomes unstable. Usually, the decrease in L* is considered to be the occurrence of browning. Fig.10 As shown in Figure D, the L*, a*, and b* values ​​gradually decrease with the extension of time, which indicates that the composite pomegranate juice beverage gradually becomes dull and darker in color during storage, but is generally within an acceptable range. Fig.10 E and Fig.10 As shown in Figure F, with the extension of time, the soluble solid content and pH value did not change much, the solid content was maintained at about 17%, and the pH was maintained at about 3.3. This is because the compound used concentrated pomegranate juice, which does not have some sugar degradation and active enzymes that affect the change of pH.

[0203] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the solution. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents based on the understanding of the present solution without departing from the purpose and scope of the technical solution of the present invention, which should be included in the scope of the claims of the present invention.

Claims

1. A method for preparing garlic essential oil inclusion compound liposomes, characterized in that: The method comprises dispersing the garlic essential oil microcapsules obtained by cyclodextrin embedding treatment in water, and then adding the microcapsules into a lipid membrane for hydration to obtain a garlic essential oil inclusion compound liposome aqueous dispersion. The hydration time is 5 to 15 minutes; the garlic essential oil microcapsules are dispersed in water, and the mass volume concentration of the garlic essential oil microcapsules in the water dispersion is 0.85 to 1.25 g / L; The lipid membrane is obtained by dissolving cholesterol and phospholipids in a solvent to obtain a lipid solution, and then removing the solvent; The mass ratio of the garlic essential oil microcapsules to the phospholipids is 1:4-10; The mass ratio of cholesterol to phospholipid is 1:2-4; The particle size distribution of the liposomes in the liposome aqueous dispersion is 50nm to 800nm.

2. The method for preparing garlic essential oil inclusion compound liposome according to claim 1, characterized in that: The solvent is anhydrous ethanol, methanol, n-hexane or chloroform.

3. The method for preparing garlic essential oil inclusion compound liposome according to claim 2, characterized in that: The lipid membrane is obtained by dissolving cholesterol, phospholipids and antioxidants in a solvent to obtain a lipid solution, and then removing the solvent.

4. The method for preparing garlic essential oil inclusion compound liposome according to claim 3, characterized in that: The antioxidant is vitamin E, vitamin C, n-acetylcysteine, glutathione or beta-carotene.

5. The method for preparing garlic essential oil inclusion compound liposome according to claim 1, characterized in that: The cyclodextrin is β-cyclodextrin, α-cyclodextrin or γ-cyclodextrin.

6. The method for preparing garlic essential oil inclusion compound liposome according to any one of claims 1 to 5, characterized in that: The steps include: S1. dissolving cholesterol and phospholipid in a solvent at a mass ratio of 1:2 to 4 to obtain a lipid solution; S2. The lipid solution is placed in a container and a lipid film is formed, and an aqueous dispersion of garlic essential oil microcapsules encapsulated by cyclodextrin is added to the lipid film to be hydrated to obtain an aqueous liposome dispersion; S3. The liposome aqueous dispersion obtained in S2. is subjected to ultrasonic treatment and microporous organic filter membrane treatment.

7. The method for preparing garlic essential oil inclusion compound liposome according to claim 6, characterized in that: The ultrasonic treatment in step S3 is to control the particle size distribution of the liposomes in the liposome aqueous dispersion to be between 50 nm and 800 nm.

8. Use of the garlic essential oil inclusion compound liposome prepared by the method for preparing the garlic essential oil inclusion compound liposome according to any one of claims 1 to 7 in preparing blood lipid lowering drugs, auxiliary blood lipid lowering health food or functional beverage.

9. A composite pomegranate juice beverage, characterized in that: The composite pomegranate juice beverage comprises 10% to 15% by volume of concentrated pomegranate juice and 1.5% to 2.5% by volume of a garlic essential oil inclusion liposome aqueous dispersion prepared by the method according to any one of claims 1 to 7; the composite pomegranate juice beverage also contains white sugar and citric acid, wherein the mass volume concentration of the white sugar is 40 to 80 g / L; and the mass volume concentration of the citric acid is 0.2 to 0.6 g / L.

Citation Information

Patent Citations

  • Ginger and garlic enteric-coated tablet and preparation method thereof

    CN102961713A

  • Concentrated granada juice and preparation technology thereof

    CN101167589A

  • Allicin nano liposome and preparation method and application thereof

    CN103263408A

  • Garlic oil vitamin E soft capsule and preparation method thereof

    CN106729009A

  • Antioxidation fruit juice beverage and preparation method thereof

    CN107136354A